Israel Englander Ac Immune Sa Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ac Immune Sa stock. As of the latest transaction made, Millennium Management LLC holds 94,900 shares of ACIU stock, worth $314,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,900

Previous 291,532 67.45%

Holding current value

$314,119

Previous $591,000 51.61%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.99 - $3.04 $1.2 Million - $1.83 Million	603,000 Added 206.84%	894,532 $2.7 Million
Q2 2025 Aug 14, 2025	BUY	$1.48 - $2.2 $116,597 - $173,320	78,782 Added 37.03%	291,532 $591,000
Q1 2025 May 15, 2025	BUY	$1.87 - $2.98 $175,237 - $279,255	93,710 Added 78.72%	212,750 $397,000
Q4 2024 Feb 14, 2025	SELL	$2.67 - $3.75 $125,757 - $176,625	-47,100 Reduced 28.35%	119,040 $321,000
Q3 2024 Nov 14, 2024	BUY	$2.99 - $4.2 $178,733 - $251,063	59,777 Added 56.2%	166,140 $628,000

Q2 2024 Aug 14, 2024	BUY	$2.29 - $4.87 $243,571 - $517,987	106,363 New	106,363 $424,000
Q2 2023 Aug 14, 2023	SELL	$1.85 - $3.4 $124,865 - $229,483	-67,495 Reduced 56.71%	51,532 $152,000
Q1 2023 May 15, 2023	BUY	$2.13 - $2.49 $21,770 - $25,450	10,221 Added 9.39%	119,027 $279,000
Q4 2022 Feb 14, 2023	BUY	$1.72 - $3.12 $187,146 - $339,474	108,806 New	108,806 $222,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $195,383 - $305,817	-40,452 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $223,925 - $301,215	-36,117 Reduced 47.17%	40,452 $271,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $1.06 Million - $1.47 Million	-175,457 Reduced 69.62%	76,569 $607,000
Q1 2021 May 17, 2021	BUY	$5.32 - $8.96 $1.23 Million - $2.07 Million	230,886 Added 1092.18%	252,026 $1.92 Million
Q4 2020 Feb 16, 2021	SELL	$4.47 - $5.58 $1.13 Million - $1.41 Million	-252,989 Reduced 92.29%	21,140 $109,000
Q3 2020 Nov 16, 2020	SELL	$4.78 - $9.06 $1.16 Million - $2.2 Million	-243,107 Reduced 47.0%	274,129 $1.34 Million
Q2 2020 Aug 14, 2020	SELL	$6.57 - $8.3 $55,470 - $70,076	-8,443 Reduced 1.61%	517,236 $3.48 Million
Q1 2020 May 14, 2020	BUY	$4.24 - $9.89 $2.02 Million - $4.7 Million	475,701 Added 951.82%	525,679 $3.63 Million
Q4 2019 Feb 14, 2020	SELL	$4.56 - $8.78 $332,095 - $639,429	-72,828 Reduced 59.3%	49,978 $426,000
Q3 2019 Nov 14, 2019	SELL	$4.8 - $5.89 $495,206 - $607,659	-103,168 Reduced 45.65%	122,806 $607,000
Q2 2019 Aug 15, 2019	BUY	$4.72 - $5.88 $972,579 - $1.21 Million	206,055 Added 1034.46%	225,974 $1.25 Million
Q2 2019 Aug 14, 2019	SELL	$4.72 - $5.88 $707,244 - $881,059	-149,840 Reduced 88.27%	19,919 $2.98 Million
Q1 2019 May 14, 2019	BUY	$3.65 - $11.68 $619,620 - $1.98 Million	169,759 New	169,759 $857,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

26.8M

Call Options Held

94.9K

Put Options Held

22.5K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $276M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account